Blockchain Registration Transaction Record

Immune Biomarkers May Predict Bladder Cancer Therapy Response

Northwestern Medicine identifies immune biomarkers that may predict response to BCG bladder cancer therapy, paving the way for personalized treatment. Discover how this breakthrough, highlighted by TinyGems, could impact patients and companies like Calidi Biotherapeutics.

This discovery matters because it could spare bladder cancer patients from ineffective BCG therapy and its harsh side effects, while guiding them toward more effective treatments like those from Calidi Biotherapeutics. As personalized medicine advances, such biomarkers promise to improve survival rates and quality of life for thousands diagnosed annually.